Guest guest Posted October 15, 2003 Report Share Posted October 15, 2003 Illinois launches website, petition to challenge FDA Web site for drug importation latest move by Blagojevich by Maura Kelly Chicago Tribune staff reporter Published October 14, 2003, 4:36 PM CDT Gov. Rod Blagojevich is enlisting the help of consumers in his high- profile battle with the Food and Drug Administration over a proposal to import drugs from Canada for state employees and retirees. On Tuesday, he launched a Web site that includes information about buying prescription drugs from companies in Canada to take advantage of lower prices there. He also encouraged consumers to fill out an online petition in support of the proposal and appeared on NBC's " Today " show to discuss the idea, which the FDA and Speaker of the House Dennis Hastert oppose. " The FDA can continue to ignore our pleas. The FDA can continue to ignore our letters. They can ignore our calls, " Blagojevich said at a news conference. " But they cannot ignore the people forever. " The launching of the Web site and petition is the latest move by Blagojevich to persuade Congress to allow Illinois to import drugs from Canada, where brand-name drugs often cost less than in the United States because of government price controls and a favorable exchange rate. Illinois spent $340 million on prescription drugs for its employees and retirees last fiscal year, up 15 percent from a year earlier. But federal law prevents bringing foreign drugs into the country. The FDA warns that buying Canadian drugs presents significant, potential health risks. " You really can't trade safety for a price, " said Peter Pitts, FDA spokesman. " He (Blagojevich) can target whomever he likes. But at the end of the day, Congress makes the laws and the FDA enforces the law, " he said. Last month, Blagojevich commissioned a study on the merits of letting state employees and retirees buy drugs from Canadian companies. Four days later, he publicly urged the FDA to allow state and local governments to import drugs from Canada and solicited support for his idea from the nation's other governors. A week later, he lobbied Congress on the idea. He also has asked Attorney General Lisa Madigan's office to look into whether drug manufacturers are illegally blocking access to cheaper prescription drugs from Canada. Last week, an 11-member delegation of Illinois health and policy officials visited Canada as part of the study on the issue. The governor said he expects the study, which should be finished by the end of October, to show the idea is sound. " We're not going to violate what the FDA's rules are, but we are going to try to get the FDA to change its position and one way to do it is through the United States Congress, " Blagojevich said. " The Congress doesn't act or doesn't change things unless they hear from the people back home. " The petition is addressed to the FDA and members of Congress. The Web site includes information about the differences between American and Canadian drug prices, activity in Congress on the issue and editorials in support of drug importation efforts. The site, www.affordabledrugs.il.gov, also contains a price comparison chart of drugs bought in the United States and Canada. Jeffrey Trewhitt, a spokesman for the drug industry trade group Pharmaceutical Research and Manufacturers of America, said the petition should not make a difference in changing the law. " It's very important that we all stop and listen carefully to what the Food and Drug Administration is saying. They are saying there is a serious safety issue, " he said. On the Net: Food and Drug Administration: http://www.fda.gov/ Petition site: http://www.affordabledrugs.il.gov http://www.chicagotribune.com/news/local/chi-031014prescriptions- story,1,4430373.story?coll=chi-news-hed ------------------ Laura Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.